The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Magellan Health Inc

Nasdaq: MGLN
Last

(U.S.) $60.28

Today's change-0.27 -0.45%
Updated August 4 4:00 PM EDT. Delayed by at least 15 minutes.
 

Magellan Health Inc

Nasdaq: MGLN
Last

(U.S.) $60.28

Today's change-0.27 -0.45%
Updated August 4 4:00 PM EDT. Delayed by at least 15 minutes.

Magellan Health Inc down (U.S.)$0.27

Magellan Health Inc closed lower Tuesday, dropping (U.S.)$0.27 or 0.45% to (U.S.)$60.28. This security is unchanged over the last five days and the last 52 weeks. This security has underperformed the S&P 500 by 2.17% during the last year.

Key company metrics

  • Open(U.S.) $60.43
  • Previous close(U.S.) $60.55
  • High(U.S.) $61.48
  • Low(U.S.) $60.17
  • Bid / Ask-- / --
  • YTD % change+0.42%
  • Volume136,389
  • Average volume (10-day)309,854
  • Average volume (1-month)228,960
  • Average volume (3-month)176,182
  • 52-week range(U.S.) $52.37 to (U.S.) $73.00
  • Beta0.49
  • Trailing P/E26.63×
  • P/E 1 year forward34.10×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.26
Updated August 4 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.16%Sector:HealthcareIndustry:Managed Health Care
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue1,158981982923
Total other revenue--------
Total revenue1,158981982923
Gross profit36366149
Total cost of revenue1,121945922874
Total operating expense1,146968946898
Selling / general / administrative--------
Research & development--------
Depreciation / amortization25232424
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income11123625
Interest income (expense), net non-operating-2-2-2-3
Gain (loss) on sale of assets--------
Other--------
Income before tax10113522
Income after tax472026
Income tax, total6415-3
Net income572227
Total adjustments to net income--------
Net income before extra. items572227
Minority interest0021
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items572227
Inc. avail. to common incl. extra. items572227
Diluted net income572227
Dilution adjustment------0
Diluted weighted average shares27262627
Diluted EPS excluding extraordinary itemsvalue per share0.170.280.821.00
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.170.280.821.00